Business Description
Jointown Pharmaceutical Group Co Ltd
NAICS : 446110
SIC : 5087
ISIN : CNE100000W45
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.9 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 0.66 | |||||
Debt-to-EBITDA | 3.8 | |||||
Interest Coverage | 3.43 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.35 | |||||
Beneish M-Score | -2.56 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.3 | |||||
3-Year EBITDA Growth Rate | -3.3 | |||||
3-Year EPS without NRI Growth Rate | 3.6 | |||||
3-Year FCF Growth Rate | 24.9 | |||||
3-Year Book Growth Rate | 6.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 11.3 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.33 | |||||
9-Day RSI | 49.52 | |||||
14-Day RSI | 51.72 | |||||
6-1 Month Momentum % | 13.2 | |||||
12-1 Month Momentum % | 1.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.26 | |||||
Quick Ratio | 0.98 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 46.08 | |||||
Days Sales Outstanding | 83.34 | |||||
Days Payable | 109.38 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.35 | |||||
Dividend Payout Ratio | 0.59 | |||||
Forward Dividend Yield % | 4.35 | |||||
5-Year Yield-on-Cost % | 4.35 | |||||
Shareholder Yield % | 5.54 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 7.97 | |||||
Operating Margin % | 2.98 | |||||
Net Margin % | 1.45 | |||||
FCF Margin % | 2.12 | |||||
ROE % | 8.78 | |||||
ROA % | 2.27 | |||||
ROIC % | 10.16 | |||||
ROC (Joel Greenblatt) % | 27.07 | |||||
ROCE % | 12.85 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 14.95 | |||||
PE Ratio without NRI | 13.64 | |||||
Shiller PE Ratio | 17.74 | |||||
Price-to-Owner-Earnings | 26.31 | |||||
PEG Ratio | 1.59 | |||||
PS Ratio | 0.2 | |||||
PB Ratio | 1.31 | |||||
Price-to-Tangible-Book | 1.48 | |||||
Price-to-Free-Cash-Flow | 10.7 | |||||
Price-to-Operating-Cash-Flow | 7.94 | |||||
EV-to-EBIT | 7.96 | |||||
EV-to-EBITDA | 7.96 | |||||
EV-to-Revenue | 0.23 | |||||
EV-to-FCF | 10.69 | |||||
Price-to-Projected-FCF | 0.86 | |||||
Price-to-DCF (Earnings Based) | 0.64 | |||||
Price-to-DCF (FCF Based) | 0.34 | |||||
Price-to-Median-PS-Value | 0.57 | |||||
Price-to-Graham-Number | 0.95 | |||||
Price-to-Net-Current-Asset-Value | 4.54 | |||||
Earnings Yield (Greenblatt) % | 12.56 | |||||
FCF Yield % | 9.83 | |||||
Forward Rate of Return (Yacktman) % | 8.37 |